Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line

Citation
V. Qi et al., Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line, INT J HYPER, 17(1), 2001, pp. 38-47
Citations number
34
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF HYPERTHERMIA
ISSN journal
02656736 → ACNP
Volume
17
Issue
1
Year of publication
2001
Pages
38 - 47
Database
ISI
SICI code
0265-6736(200101)17:1<38:APGTPH>2.0.ZU;2-9
Abstract
Background: It has previously been demonstrated that Ad5CMV-p53 gene transf er, either used alone or delivered concomitantly with ionizing radiation, r esulted in cytotoxicity mediated by apoptosis in nasopharyngeal carcinoma ( NPC) cell lines. In this study, a novel approach was evaluated of combining Ad5CMV-p53 gene therapy with hyperthermia (HT), in the CNE-1 NPC cell line , which harbours a mutation in codon 249 of the p53 gene. Materials and methods: CNE-1 cells were infected using either Ad5CMV-p53 or Ad5CMV-B-gal, followed, 24 h later, by HT (43 degreesC x 0-2 h). Protein w as extracted for Western blot analysis, and apoptosis was evaluated using a cridine-orange ethidium bromide staining, followed immediately by fluoresce nt microscopy examination for the proportion of cells displaying morphologi c features of apoptosis. Results: Ad5CMV-p53 gene therapy combined with HT resulted in a dose-depend ent cytotoxicity with less than 1% clonogenic survival when 10 pfu/cell of Ad5CMV-p53 was combined with 2 h heating at 43 degreesC. Western blotting d emonstrated that treatment with Ad5CMV-p53 resulted in the rapid expression of p53, which was minimally affected by HT. The inducible form of hsp70 wa s maximally expressed at 48 h post-HT, with minimal effect when cells were additionally treated with Ad5CMV-p53. Clonogenic cytotoxicity was associate d with the development of apoptosis, with up to 70% of CNE-1 cells displayi ng morphologic features of apoptosis after the combination treatments. Conclusion: Based on the shapes of the clonogenic survival curves, Ad5CMV-p 53 gene therapy and HT appear to interact in an additive manner, suggesting the therapeutic potential of this combined treatment approach for patients with NPC.